Lokavant provides clinical trial teams with an intelligence platform that improves the time, cost, and quality of trial planning and execution through data-driven analytics solutions. Lokavant's platform aggregates and integrates real-time data from disparate trial data sources, and powers advanced analytics enabled by its compendium of proprietary trial data. The suite of applications built on the platform allows study teams to proactively manage their studies and surface insights, driving efficiencies in all scientific and operational use cases.
Watch our video
Predictive factors of clinical trial participant discontinuation
Using our proprietary historical trial data, Lokavant conducted an analysis to investigate key predictive factors that increased or decreased risk of participant discontinuation in COVID-19 impacted clinical trials.
New Lokavant advanced analytics improve enrollment projections
Using machine learning models and a combination of historical and within-trial data, Lokavant was able to predict key enrollment outcomes earlier in a study’s trajectory and with 95% accuracy
How Decentralized Approaches Mitigate Pandemic-Driven Enrollment Challenges Report
Lokavant partnered with THREAD to conduct the first ever impact analysis of DCTs on key performance indicators during the pandemic. Using proprietary data from over 300 ongoing COVID-impacted trials and data from THREAD, Lokavant’s analytical platform showcased the ability of decentralized approaches to mitigate COVID-related risks.